Increased left ventricular mass or hypertrophy (LVH) is an independent risk factor for cardiovascular events. Genetic variation, most commonly in genes encoding the protein constituents of the sarcomere, is an important primary cause of LVH that results in hypertrophic cardiomyopathy (HCM). Genetic studies of HCM patients identify pathogenic mutations in 50-60% of adult-onset familial HCM, ~30% of adult-onset sporadic HCM and ~40% of pediatric-onset HCM. Causes of LVH that clinically presents as HCM in ~50% of adults and children, particularly in those without familial disease, remains unknown. To address this gap in knowledge, we will perform integrated analyses of genomic DNA and cardiac tissue RNA in hypertrophic subjects without a recognized genetic etiology. We will search for undetected germline and somatic variants in the nuclear and mitochondrial genomes through sequenced-based strategies and will consider pathogenic etiologies (Aim 1). To assess the pathogenicity of novel sequence variants and genes we will build upon existing RNAseq datasets to determine if candidate genes participate in hypertrophic signaling pathways and we use high-throughput strategies to modulate candidate gene expression in mice and perform detailed cardiac analyses (Aim 2). Approximately 10% of the general population carries rare non- synonymous variants in sarcomere protein genes without developing overt HCM. To understand discordance in genotype and phenotype, we will map rare non-synonymous, definitive familial HCM mutations and population-identified sarcomere variants on 3-D structures of myofilament proteins, and assess their function in myocytes derived from differentiated isogenic iPS cells (Aim 3). Collectively these studies will expand the repertoire of genetic and acquired causes of HCM and LVH and improve the accurate prediction of phenotypes that arise from rare genetic variation.
Our aims will: 1) Assess genetic variation in cardiac tissue and genomes of patients with LVH using high-throughput DNA sequencing methods. 2) Demonstrate that novel molecules cause or modify LVH in vivo. 3) Define the pathogenicity of rare human sarcomere protein gene variants found in the general population.

Public Health Relevance

Our studies will help understand the causes of inherited and non-inherited heart disease. This understanding should lead to improved diagnostic approaches to left ventricular hypertrophy and will allow patients to benefit from new therapeutic approaches to this condition. Such studies will eventually reduce the medical 'cost'of cardiomyopathy.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Wang, Lan-Hsiang
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Medical School
Schools of Medicine
United States
Zip Code
Burke, Michael A; Chang, Stephen; Wakimoto, Hiroko et al. (2016) Molecular profiling of dilated cardiomyopathy that progresses to heart failure. JCI Insight 1:
Eminaga, Seda; Teekakirikul, Polakit; Seidman, Christine E et al. (2016) Detection of Cell Proliferation Markers by Immunofluorescence Staining and Microscopy Imaging in Paraffin-Embedded Tissue Sections. Curr Protoc Mol Biol 115:14.25.1-14.25.14
Davis, Jennifer; Davis, L Craig; Correll, Robert N et al. (2016) A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy. Cell 165:1147-59
Ware, James S; Li, Jian; Mazaika, Erica et al. (2016) Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med 374:233-41
Green, Eric M; Wakimoto, Hiroko; Anderson, Robert L et al. (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617-21
Roberts, Angharad M; Ware, James S; Herman, Daniel S et al. (2015) Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 7:270ra6
Muehlschlegel, Jochen D; Christodoulou, Danos C; McKean, David et al. (2015) Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome. Anesthesiology 122:537-50
Jiang, Jianming; Burgon, Patrick G; Wakimoto, Hiroko et al. (2015) Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis. Proc Natl Acad Sci U S A 112:9046-51
Huang, Zhan-Peng; Kataoka, Masaharu; Chen, Jinghai et al. (2015) Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis. J Clin Invest 125:4122-34
Barefield, David; Kumar, Mohit; Gorham, Joshua et al. (2015) Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. J Mol Cell Cardiol 79:234-43

Showing the most recent 10 out of 45 publications